The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Chronic Pain Treatment Market - 2022-2030
US$ 2,999.00
The Chronic Pain Treatment Market was valued at US$ 83.8 billion in 2022 and is anticipated to reach US$ 143.2 billion by 2030, at a CAGR of 0.071 from 2026 to 2032. The report delivers in-depth insig...
January 2026
219 pages
Cushing's Syndrome Market - 2023-2031
US$ 2,999.00
The Cushing's Syndrome Market was valued at US$ 146.5 million in 2023 and is anticipated to reach US$ 291.1 million by 2031, at a CAGR of 0.0896 from 2026 to 2032. The report delivers in-depth insight...
January 2026
210 pages
Post-Bariatric Hypoglycemia Market - 2023-2031
US$ 2,999.00
The Post-Bariatric Hypoglycemia Market was valued at US$ 206.55 million in 2023 and is anticipated to reach US$ 341.83 million by 2031, at a CAGR of 0.065 from 2026 to 2032. The report delivers in-dep...
January 2026
223 pages
Non-PVC IV Bags Market - Forecast from 2026 to 2031
US$ 3,950.00
Non-PVC IV Bags Market, sustaining a 5.13% CAGR, is anticipated to reach USD 3.041 billion in 2031 from USD 2.252 billion in 2025. The non-PVC IV bags market is experiencing significant growth, driven...
January 2026
141 pages
Pemphigus Vulgaris Treatment Market - 2023-2031
US$ 2,999.00
The Pemphigus Vulgaris Treatment Market was valued at US$ 473.4 million in 2023 and is anticipated to reach US$ 896.1 million by 2031, at a CAGR of 0.083 from 2026 to 2032. The report delivers in-dept...
January 2026
243 pages
The 2027-2032 World Outlook for Acetaminophen (Paracetamol)
US$ 1,195.00
This study covers the world outlook for acetaminophen (paracetamol) across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... P.I.E., for acetaminophen (paracetamol). It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
288 pages
The 2027-2032 World Outlook for Analgesics
US$ 1,195.00
This study covers the world outlook for analgesics across more than 190 countries. For each ... unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent ... P.I.E., for analgesics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also show ...
January 2026
287 pages
The 2027-2032 World Outlook for Analgesics (Painkillers)
US$ 1,195.00
This study covers the world outlook for analgesics (painkillers) across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for analgesics (painkillers). It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
The 2027-2032 World Outlook for Antacids
US$ 1,195.00
This study covers the world outlook for antacids across more than 190 countries. For each year reported, ... . This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product ...
January 2026
287 pages
The 2027-2032 World Outlook for Botulinum Toxins
US$ 1,195.00
This study covers the world outlook for botulinum toxins across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for botulinum toxins. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
The 2027-2032 World Outlook for Children's Analgesics
US$ 1,195.00
This study covers the world outlook for children's analgesics across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for children's analgesics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
The 2027-2032 World Outlook for Children's Cough, Cold, and Allergy Medicines
US$ 1,195.00
This study covers the world outlook for children's cough, cold, and allergy medicines across more than 190 countries. For each year ... , or the P.I.E., for children's cough, cold, and allergy medicines. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I ...
January 2026
293 pages
The 2027-2032 World Outlook for Cold, Cough, and Sore Throat Medications
US$ 1,195.00
This study covers the world outlook for cold, cough, and sore throat medications across more than 190 countries. For each year ... demand, or the P.I.E., for cold, cough, and sore throat medications. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I ...
January 2026
292 pages
The 2027-2032 World Outlook for Cold Sore Medicines
US$ 1,195.00
This study covers the world outlook for cold sore medicines across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for cold sore medicines. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
The 2027-2032 World Outlook for Combination Cough-Cold-Allergy Medicines
US$ 1,195.00
This study covers the world outlook for combination cough-cold-allergy medicines across more than 190 countries. For each year ... demand, or the P.I.E., for combination cough-cold-allergy medicines. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also ...
January 2026
292 pages
The 2027-2032 World Outlook for Cough, Cold, and Allergy Remedies
US$ 1,195.00
This study covers the world outlook for cough, cold, and allergy remedies across more than 190 countries. For each year reported, ... demand, or the P.I.E., for cough, cold, and allergy remedies. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also ...
January 2026
290 pages
The 2027-2032 World Outlook for Cough and Cold Remedies
US$ 1,195.00
This study covers the world outlook for cough and cold remedies across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... P.I.E., for cough and cold remedies. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
The 2027-2032 World Outlook for Crami
US$ 1,195.00
This study covers the world outlook for crami across more than 190 ... report does not discuss the specific players in the market serving the latent demand, nor specific details at ... also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also show my estimates of ...
January 2026
287 pages
The 2027-2032 World Outlook for Cystic Fibrosis Drugs
US$ 1,195.00
This study covers the world outlook for cystic fibrosis drugs across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for cystic fibrosis drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
The 2027-2032 World Outlook for Decongestants
US$ 1,195.00
This study covers the world outlook for decongestants across more than 190 countries. For each year reported, ... . This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product ...
January 2026
287 pages
The 2027-2032 World Outlook for Diabetic Retinopathy Therapeutics
US$ 1,195.00
This study covers the world outlook for diabetic retinopathy therapeutics across more than 190 countries. For each year reported, ... demand, or the P.I.E., for diabetic retinopathy therapeutics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also ...
January 2026
290 pages
The 2027-2032 World Outlook for Digestion Aids
US$ 1,195.00
This study covers the world outlook for digestion aids across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for digestion aids. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country ...
January 2026
287 pages
The 2027-2032 World Outlook for Drugs
US$ 1,195.00
This study covers the world outlook for drugs across more than 190 countries. For each year reported, ... . This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product ...
January 2026
288 pages
The 2027-2032 World Outlook for Drugs for Alzheimer's and Parkinson's Diseases
US$ 1,195.00
This study covers the world outlook for drugs for Alzheimer's and Parkinson's diseases across more than 190 countries. For each year ... or the P.I.E., for drugs for Alzheimer's and Parkinson's diseases. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country ...
January 2026
294 pages
The 2027-2032 World Outlook for Erectile Dysfunction Drugs
US$ 1,195.00
... study covers the world outlook for erectile dysfunction drugs across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for erectile dysfunction drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
The 2027-2032 World Outlook for Erythropoietins
US$ 1,195.00
This study covers the world outlook for erythropoietins across more than 190 countries. For each year reported, ... . This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product ...
January 2026
287 pages
The 2027-2032 World Outlook for Glaucoma Pharmaceuticals
US$ 1,195.00
This study covers the world outlook for Glaucoma pharmaceuticals across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for Glaucoma pharmaceuticals. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
